# Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/liver-fibrosis-and-mafld-from-molecular-aspects-to-novel-pharmacological/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Weiyi Qu,Tengfei Ma,Jingjing Cai,Xiao‐Jing Zhang,Peng Zhang,Zhi‐Gang She,Feng Wan,Hongliang Li |
| Citations | 61 |
| DOI | 10.3389/fmed.2021.761538 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.3389/fmed.2021.761538 |
| OpenAlex ID | https://openalex.org/W3211313829 |
| PMID | 34746195 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Tengfei Ma](https://scholariq.org/researchers/tengfei-ma/)

## Paper journal

- [Frontiers in Medicine](https://scholariq.org/journals/frontiers-in-medicine/)

## Paper primary topic

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Paper topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Endoplasmic Reticulum Stress and Disease](https://scholariq.org/topics/endoplasmic-reticulum-stress-and-disease/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
